Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering

Biotech
Monday, October 16th, 2023 8:33 pm EDT

Key Points

Private Placement and Fundraising: Alpha Cognition Inc. has completed a second closing of its private placement of units, issuing 1,596,830 units at a price of US$0.22 per unit, resulting in gross proceeds of US$351,303. The company has raised a total of US$1.7 million in gross proceeds from the offering, with plans to continue the offering for an additional US$4.8 million. Each unit includes a common share and a half warrant, which can be used to purchase an additional common share at a price of US$0.31 for a period of three years.
Intended Use of Proceeds: The company plans to use the net proceeds from the private placement for various purposes, including research and development, general and administrative matters, and working capital. Additionally, the company may conduct additional closings as part of the private placement. The article also highlights that the securities being offered have not been registered in the United States and cannot be sold to U.S. persons unless they are registered or an exemption from registration is available.

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition” or the “Company”) announces that it has completed a second closing pursuant to its previously announced private placement of units of the Company. Pursuant to the second closing, the Company issued 1,596,830 units of the Company at a price of US$0.22 per unit for gross proceeds of US$351,303. Each Unit consists of a common share and a half warrant, with each whole warrant entitling the holder to purchase an additional common share at a price of US$0.31 for a period of three years. The gross proceeds of the offering received to date are US$1.7 million. The Company is continuing the offering of units on the same terms for up to an additional US$4.8 million.

The Company expects to use the net proceeds from the private placement for research and development, general and administrative matters, and working capital. The Company may complete additional closings pursuant to the private placement.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws, and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.